N Engl J Med 325 (19): 1342-8, 1991.[PUBMED Abstract] Falkson G, Gelman RS, Glick J, et al.: Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment.
An Eastern Cooperative Oncology Group study.
Ann Oncol 3 (9): 768-70, 1992.[PUBMED Abstract] Park YH, Jung KH, Im SA, et al.: Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02.